Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Hormone patch may provide some increase in sexual desire in menopausal women

26.07.2005


A testosterone patch may produce modest increases in sexual desire and frequency of satisfying sexual experiences in women who develop distressful, low sexual desire following hysterectomy and removal of the fallopian tubes and ovaries, according to a study in the July 25 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

Diminished sexual desire has been reported by 30 to 50 percent of women who undergo surgical menopause (menopause induced by the surgical removal of both ovaries), according to background information in the article. In one form of female sexual dysfunction, hypoactive sexual desire disorder, a chronic absence of desire for sexual activity results in personal distress. When the ovaries are removed (oophorectomy), blood levels of sex hormones, including testosterone, drop. Although some women see improvements in sexual functioning with estrogen therapy alone, previous studies suggest that the combination of estrogen and testosterone is more effective in preserving sexual desire.

Glenn D. Braunstein, M.D., of Cedars-Sinai Medical Center, Los Angeles, and colleagues conducted a 24-week, randomized, double blind, multicenter clinical trial in women who developed distressful low sexual desire after surgical menopause and were receiving oral estrogen therapy. The 447 women (aged 24 to 70 years) were randomized to receive placebo or testosterone patches twice weekly in one of three progressively higher doses. Testosterone levels were checked at baseline, 12 and 24 weeks. Changes in sexual desire and frequency of satisfying sexual activity were determined on the basis of a woman’s reports on standardized questionnaire and sexual function activity log.



The researchers found that compared with women receiving placebo, women receiving the middle dosage (300 micrograms per day) had greater increases from baseline in questionnaire scores for sexual desire (67 percent increase over baseline compared with 48 percent increase over baseline for placebo) and in reported frequency of satisfying sexual activity (79 percent over baseline compared with 43 percent over baseline for the placebo group). The low dosage group showed no evidence of a treatment effect. The women in the high dosage group had increases in baseline sexual desire similar to the middle dosage group, but were no different from the placebo group in changes in frequency of satisfying sexual activity.

"Testosterone, 300 ìg/d [microgram per day] administered by a patch, significantly improved sexual desire and the frequency of total satisfying sexual activity in surgically menopausal women with hypoactive sexual desire disorder," the authors conclude. "These findings were generally consistent across all sexual function instruments [questionnaires and logs], end points, and time points, and highlight the important role that testosterone may play in women’s sexual health. Additional studies should be undertaken to further assess the efficacy and safety of this treatment."

Editor’s Note: This study was funded by research grants from Procter & Gamble Pharmaceuticals, Mason, Ohio. Dr. Braunstein is a consultant for Procter & Gamble Pharmaceuticals. Co-author Jan L. Shifren, M.D., is a consultant for and receives research support from Procter & Gamble Pharmaceuticals. Co-author James A. Simon, M.D., is a consultant for and receives research support from a number of firms including Procter & Gamble Pharmaceuticals. Co-author Gloria Bachman, M.D., is a consultant for Procter & Gamble Pharmaceuticals and is on their speaker’s bureau. Co-author Nelson B. Watts, M.D., receives consultant fees, honoraria, and research support from Procter & Gamble Pharmaceuticals.

Editorial: Goldilocks and Menopause

In an editorial accompanying the article, Robert A. Vigersky, M.D., of Walter Reed Army Medical Center, Washington, D.C., writes, "The benefits found by Braunstein and colleagues are modest and not clearly dose related. Using the Profile of Female Sexual Function (PFSF) … they found a statistically significant increase in only two of the seven domains of sexual function at the 300-ìg/d dose but not at the 450-ìg/d dose of a transdermal testosterone patch. … Despite this apparent robust increase [in the sexual desire and sexual arousal scores], when put in the descriptive terms of the questionnaire, the testosterone treatment only raised the level of sexual function from ’seldom’ to ’sometimes.’ Similarly, the frequency of satisfying sexual activity increased by 79 percent in the testosterone-treated group compared with 43 percent in the placebo group, but on a monthly basis this was an absolute increase from three to five episodes."

"Goldilocks has been around for almost 200 years," Dr. Vigersky concludes. "Should she ever develop HSDD [hypoactive sexual desire disorder], it is still not clear if a 300-ìg transdermal testosterone patch is ’just right’ for her. Hopefully, further studies will be available when and if she needs to be treated.

Kelli Hanley | EurekAlert!
Further information:
http://www.jamamedia.org

More articles from Studies and Analyses:

nachricht The importance of biodiversity in forests could increase due to climate change
17.11.2017 | Deutsches Zentrum für integrative Biodiversitätsforschung (iDiv) Halle-Jena-Leipzig

nachricht Win-win strategies for climate and food security
02.10.2017 | International Institute for Applied Systems Analysis (IIASA)

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: A “cosmic snake” reveals the structure of remote galaxies

The formation of stars in distant galaxies is still largely unexplored. For the first time, astron-omers at the University of Geneva have now been able to closely observe a star system six billion light-years away. In doing so, they are confirming earlier simulations made by the University of Zurich. One special effect is made possible by the multiple reflections of images that run through the cosmos like a snake.

Today, astronomers have a pretty accurate idea of how stars were formed in the recent cosmic past. But do these laws also apply to older galaxies? For around a...

Im Focus: Visual intelligence is not the same as IQ

Just because someone is smart and well-motivated doesn't mean he or she can learn the visual skills needed to excel at tasks like matching fingerprints, interpreting medical X-rays, keeping track of aircraft on radar displays or forensic face matching.

That is the implication of a new study which shows for the first time that there is a broad range of differences in people's visual ability and that these...

Im Focus: Novel Nano-CT device creates high-resolution 3D-X-rays of tiny velvet worm legs

Computer Tomography (CT) is a standard procedure in hospitals, but so far, the technology has not been suitable for imaging extremely small objects. In PNAS, a team from the Technical University of Munich (TUM) describes a Nano-CT device that creates three-dimensional x-ray images at resolutions up to 100 nanometers. The first test application: Together with colleagues from the University of Kassel and Helmholtz-Zentrum Geesthacht the researchers analyzed the locomotory system of a velvet worm.

During a CT analysis, the object under investigation is x-rayed and a detector measures the respective amount of radiation absorbed from various angles....

Im Focus: Researchers Develop Data Bus for Quantum Computer

The quantum world is fragile; error correction codes are needed to protect the information stored in a quantum object from the deteriorating effects of noise. Quantum physicists in Innsbruck have developed a protocol to pass quantum information between differently encoded building blocks of a future quantum computer, such as processors and memories. Scientists may use this protocol in the future to build a data bus for quantum computers. The researchers have published their work in the journal Nature Communications.

Future quantum computers will be able to solve problems where conventional computers fail today. We are still far away from any large-scale implementation,...

Im Focus: Wrinkles give heat a jolt in pillared graphene

Rice University researchers test 3-D carbon nanostructures' thermal transport abilities

Pillared graphene would transfer heat better if the theoretical material had a few asymmetric junctions that caused wrinkles, according to Rice University...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Ecology Across Borders: International conference brings together 1,500 ecologists

15.11.2017 | Event News

Road into laboratory: Users discuss biaxial fatigue-testing for car and truck wheel

15.11.2017 | Event News

#Berlin5GWeek: The right network for Industry 4.0

30.10.2017 | Event News

 
Latest News

NASA detects solar flare pulses at Sun and Earth

17.11.2017 | Physics and Astronomy

NIST scientists discover how to switch liver cancer cell growth from 2-D to 3-D structures

17.11.2017 | Health and Medicine

The importance of biodiversity in forests could increase due to climate change

17.11.2017 | Studies and Analyses

VideoLinks
B2B-VideoLinks
More VideoLinks >>>